Sunday, May 29, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home News

Study identifies a genetic mutation linked to high risk of lethal childhood leukemia

by Medical Finance
in News
Study identifies a genetic mutation linked to high risk of lethal childhood leukemia
9
SHARES
99
VIEWS
Share on FacebookShare on Twitter

A genetic variant changing just one base pair of nucleotides greatly increases risk of a high-risk subtype of childhood acute lymphoblastic leukemia (ALL), according to a Northwestern Medicine study published in Nature Genetics.

Tracing this oncogenic pathway provides a template for future studies of other types of cancers as well, according to Feng Yue, PhD, the Duane and Susan Burnham Professor of Molecular Medicine and co-senior author of the study.

In this study, we discovered how an inherited gene variation regulates multiple known ALL oncogenes through a cascade of interactions. If we can manipulate this pathway, we could potentially prevent the development of this cancer.”


Feng Yue, associate professor of Biochemistry and Molecular Genetics, of Pathology and director of the Center for Cancer Genomics at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Childhood acute lymphoblastic leukemia (ALL) is the most common leukemia among children. Genetic contributions to childhood ALL have been previously identified, but the mutations that lead to subtypes — such as the more-lethal “Ph-like” ALL — have remained mostly uncharacterized.

In the current study, investigators at Feinberg and at St. Jude Children’s Research Hospital performed genetic sequencing in more than 5,000 children with ALL, identifying a non-coding mutation that was associated with significantly higher risk of Ph-like ALL.

Because this genetic variant is non-coding, the scientists needed to determine which gene it controls and how it contributes to oncogenesis. Yue and his collaborators demonstrated that the mutation created an active enhancer: a genetic control element that influences its target from thousands of loci away.

Through successive rounds of biochemical experiments, the authors demonstrated that this newly created enhancer could significantly increase the transcription of the gene GATA3, which is a known factor that can further regulate many other genes.­­­ In this particular scenario, GATA3 upregulates a pair of known oncogenes: CRLF2 and JAK-STAT.

“GATA3 is a middleman between the harmful variant and the oncogenes,” said Yue, who is also the director of the Center for Advanced Molecular Analysis at the Institute for Augmented Intelligence in Medicine. These oncogenes are known to promote cell proliferation and growth of the cancer — helping explain why the Ph-like subtype is more lethal compared to other forms of ALL.

Charting this pathway will aid future therapy design, Yue said. In particular, since either directly targeting GATA3 for inhibition or manipulating its enhancers through CRISPR/Cas9 genome editing  could disable both downstream oncogenes, it is a promising line of study.

Further, utilizing large genetic screens to identify influential mutations is a model that could be used in other cancer types, as many are likely to have similar genetic mechanisms that provide therapeutic opportunities, according to Yue.

“The human genome has 3 billion base pairs, and what we’ve shown here is that one base pair difference can influence this pathogenic pathway — it’s unbelievable,” Yue said. “There are thousands of other generic variants which are associated with different human diseases and traits. Such framework could be applied to many other types of cancer, as well.”

Source:

Journal reference:

Yang, H., et al. (2022) Noncoding genetic variation in GATA3 increases acute lymphoblastic leukemia risk through local and global changes in chromatin conformation. Nature Genetics. doi.org/10.1038/s41588-021-00993-x.

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

Study: Evaluation of binding performance of bioactive compounds against main protease and mutant model spike receptor-binding domain of SARS-CoV-2: Docking, ADMET properties and molecular dynamics simulation study. Image Credit: Juan Gaertner / Shutterstock.com

Acacetin shows potency against SARS-CoV-2 spike protein

by Medical Finance
May 28, 2022
0

In a recent Journal of the Indian Chemical Society study, researchers use molecular docking to screen 12 phytocompounds and evaluate...

Researchers discover how ovarian cancer hides from the body’s immune system

A comprehensive rule book for the design of safe and efficient therapeutic cells

by Medical Finance
May 28, 2022
0

Therapies based on engineered immune cells have recently emerged as a promising approach in the treatment of cancer. Compared to...

Microbes in animals’ guts influence diet selection behavior, research shows

Microbes in animals’ guts influence diet selection behavior, research shows

by Medical Finance
May 28, 2022
0

Eggs or yogurt, veggies or potato chips? We make decisions about what to eat every day, but those choices may...

Study: Flavonols and Dihydroflavonols Inhibit the Main Protease Activity Of SARS-Cov-2 And the Replication of Human Coronavirus 229E. Image Credit: photo_gonzo / Shutterstock.com

Quercetin and other plant flavonols show anti-SARS-CoV-2 activity

by Medical Finance
May 29, 2022
0

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in December 2019 and ultimately led to the current...

Scientists unravel how blood cells mount the first line of defense against viruses

Novel genetic mapping study traces links between DNA variations and blood proteins

by Medical Finance
May 28, 2022
0

A new genetic mapping study led by researchers at the Johns Hopkins Bloomberg School of Public Health traces links between...

Omicron-specific mRNA vaccine generates immune responses in mice, hamsters and Macaques

Omicron-specific mRNA vaccine generates immune responses in mice, hamsters and Macaques

by Medical Finance
May 28, 2022
0

As of March 7, 2022, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected over 446 million worldwide and...

Next Post
Researchers focus on how bacterial cells adapt and resist antibiotics

Researchers focus on how bacterial cells adapt and resist antibiotics

Study: Alzheimer

Study links COVID-19 inflammatory manifestations in brain lysates to Alzheimer’s Disease markers

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • Study: Emergence of new subgenomic mRNAs in SARS-CoV-2. Image Credit: CROCOTHERY/Shutterstock
    Study suggests SARS-CoV-2 is undergoing evolutionary changes at the functional RNA level in addition to the amino acid level
  • Study: Age and vitamin D affect the magnitude of the antibody response to the first dose of the SARS-CoV-2 BNT162b2 vaccine. Image Credit: Rido/Shutterstock
    Influence of vitamin D and age on first SARS-CoV-2 vaccine dose efficacy
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply